Handan Jiaxin Liupin Biotechnology Co., Ltd
published extensive research in Current Pharmaceutical Design (2018) showing BPC-157's ability to stimulate growth factor expression, including vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF)
The results: 35% reduction in body mass 30% decrease in adipocyte size 40% decrease in adipocyte volume No change in food intake (meaning the weight loss was purely metabolic) Cholesterol levels normalized to those of lean mice This is fundamentally different from appetite suppressants like GLP-1 agonists
Lite Medical offers physician-formulated nutrient therapies to support energy, immune health, and wellness
storage at ambient temperature in darkness is recommended Precautions & Notes Stability may be affected by light, heat, and extreme pH Experimental outcomes depend on concentration, model system, and formulation Appropriate controls are recommended for enzymatic and cellular assays Intended strictly for laboratory research use
Online purchasing allows customers to compare products, review specifications, and place orders from anywhere in the country